RBM protein family: Focusing on the occurrence, progression and treatment of cancer
Medical Oncology · 2026
DOI: 10.1007/s12032-026-03439-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Oncology, 2026. Verfasst von Huhu Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, 266071, Shandong, China. Hauptthemen laut MEDLINE: Neoplasms, RNA-Binding Proteins. Die Arbeit nennt 110 Literaturangaben. Gefördert von: Grants from the National Natural Science Foundation of China, Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China, Shandong Taishan Scholars Young Experts Program.
Abstract (Originalsprache)
The RNA-binding motif (RBM) protein family plays a crucial role in regulating RNA metabolism, including transcription, splicing, stability, and translation. Dysregulation of RBM proteins has been increasingly implicated in the initiation, progression, and therapeutic resistance of various cancers. This review summarizes current knowledge on the RBM protein family, with a focus on their involvement in alternative splicing and m6A RNA methylation—two key post-transcriptional mechanisms that influence cancer biology. Members such as RBM5 and RBM10 function as tumor suppressors by modulating apoptosis, cell cycle, and splicing of oncogenic transcripts, while others like RBM15 and RBM15B contribute to tumorigenesis through m6A modification and downstream signaling pathways. The dual roles of certain RBM proteins in different cancer contexts highlight their complexity and potential as both biomarkers and therapeutic targets. Further investigation into the molecular mechanisms of RBM proteins may provide new insights for cancer diagnosis and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, 266071, Shandong, China.
- Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, 266071, Shandong, China. libing_516@qdu.edu.cn.
ORCID-Profile: Bing Li
Förderung
- Grants from the National Natural Science Foundation of China
- Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
- Shandong Taishan Scholars Young Experts Program
- The Natural Science Foundation of Shandong Province
- Qingdao Natural Science Foundation Key Project
Zitieren
APA
Zhang, H., Zheng, W., Li, L., Geng, C., Wang, Y., Zhang, J., Sun, Y., Zhang, X., & Li, B. (2026). RBM protein family: Focusing on the occurrence, progression and treatment of cancer. Medical Oncology. https://doi.org/10.1007/s12032-026-03439-8
Vancouver
Zhang H, Zheng W, Li L, Geng C, Wang Y, Zhang J, et al. RBM protein family: Focusing on the occurrence, progression and treatment of cancer. Medical Oncology. 2026. doi:10.1007/s12032-026-03439-8
BibTeX
@article{Zhang2026,
author = {Zhang, Huhu and Zheng, Wenxin and Li, Lingxi and Geng, Chenhui and Wang, Yuxiang and Zhang, Jianyu and Sun, Yulan and Zhang, Xuanyu and Li, Bing},
title = {RBM protein family: Focusing on the occurrence, progression and treatment of cancer},
journal = {Medical Oncology},
year = {2026},
doi = {10.1007/s12032-026-03439-8}
}
EUVIMED